Evidence for sympathetic and adrenal involvement in the immunomodulatory effects of acute morphine treatment in rats

Journal of Pharmacology and Experimental Therapeutics

Volumn 277, Issue 2, 1996, Pages 633-645

  Fecho, Karamarie ^a   Maslonek, Kimberly A ^a   Dykstra, Linda A ^a   Lysle, Donald T ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORISONDAMINE; CONCANAVALIN A; IONOMYCIN; LIPOPOLYSACCHARIDE; MORPHINE; PHORBOL 13 ACETATE 12 MYRISTATE;

ADRENALECTOMY; ADRENERGIC SYSTEM; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE DEFICIENCY; MALE; MORPHINE ADDICTION; NATURAL KILLER CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SPLEEN CELL; SUBCUTANEOUS DRUG ADMINISTRATION; T LYMPHOCYTE;

ADRENALECTOMY; ANALGESICS, OPIOID; ANIMALS; CHLORISONDAMINE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; IMMUNOSUPPRESSIVE AGENTS; INTERFERON TYPE II; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MALE; MORPHINE; PITUITARY-ADRENAL SYSTEM; RATS; RATS, INBRED LEW; SYMPATHETIC NERVOUS SYSTEM; TETRADECANOYLPHORBOL ACETATE;

EID: 0030436301     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (71)

1. ABRASS, C K., O'CONNOR, S. W., SCARPACE, P. J. AND ABRASS, I. B.: Characterization of the β-adrenergic receptor of the rat peritoneal macrophage. J. Immunol. 135: 1338-1341, 1985.
2. AKANA, S. F., CASCIO, C. S., SHINSAKO, J. AND DALLMAN, M. F.: Corticosterone: Narrow range required for normal body and thymus weight and ACTH. Am. J. Physiol. 249: R527-R532, 1985.
3. APPEL, N. M., KIRITSY-ROY, J. A. AND VAN LOON, G. R.: Mu receptors at discrete hypothalamic and brainstem sites mediate opioid peptide-induced increases in central sympathetic outflow. Brain Res. 378: 8-20, 1986.
4. ARAI, K., LEE, F., MIYAJIMA, A , MIYATAKE, S., ARAI, N. AND YOKOTA, T.: Cytokines: Coordinators of immune and inflammatory responses. Annu. Rev. Biochem. 59: 783-836, 1990.
5. ARMANINI, D., STRASSER, T. AND WEBER, P. C.: Characterization of aldosterone binding sites in circulating human mononuclear leukocytes. Am. J. Physiol 248: E388-E390, 1985.
6. BAYER, B. M. AND FLORES, C. M.: Effects of morphine on lymphocyte function: Possible mechanisms of interaction. In Drugs of Abuse and Immune Function, ed. by R. R. Watson, pp. 151-173, CRC Press, Boca Raton, FL, 1990.
7. 2-adrenoceptor subtypes in rat brain. Biochem. Pharmacol. 37: 1145-1151, 1988.
8. 2-selective adrenoceptor antagonist (Ici 118,551). J. Cardiovasc. Pharmacol. 5: 430-137, 1983.
9. BRUNCKHORST, W. K. AND HESS, E. L.: Interactions of hormones with thymus-cell fractions. Biochim. Biophys. Acta 82: 385-393, 1964.
10. BRYANT, H. U. AND ROUDEBUSH, R. E.: Suppressive effects of morphine pellet implants on in vivo parameters of immune function. J. Pharmacol. Exp. Ther. 255: 410-414, 1990.
11. BUCKINGHAM, J. C.: Secretion of corticotropin and its hypothalamic releasing factor in response to morphine and opioid peptides. Neuroendocrinology 35: 111-116, 1982.
12. CARLSON, S. L., BROOKS, W. H. AND ROSZMAN, T. L.: Neurotransmitter-lymphocyte interactions: Dual receptor modulation of lymphocyte proliferation and cAMP production. J. Neuroimmunol. 24: 155-162, 1989.
13. CARR, D. J. J.: The role of endogenous opioids and their receptors in the immune system Proc. Soc. Exp. Biol. Med. 198: 710-720, 1991.
14. CHEN, G., PORTMAN, R. AND WICKEL, A.: Pharmacology of 1,1-dimethyl-4-phenylpiperazinium iodide, a ganglion stimulating agent. J. Pharmacol. Exp. Ther. 103: 330-336, 1951.
15. CHERWINSKI, H. M., SCHUMACHER, J. H., BROWN, K. D. AND MOSMANN, T. R.: Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays and monoclonal antibodies. J. Exp. Med. 166: 1229-1244, 1987.
16. CHILSON, O. P. AND KELLY-CHILSON, A. E.: Disulfide-linked receptors for mitogenic lectins on piglet lymphocytes. Eur. J. Immunol. 18: 1581-1586, 1988.
17. CRARY, B. BORYSENKO, M., SUTHERLAND, D. C., KUTZ, I., BORYSENKO, J. Z. AND BENSON, H.: Decrease in mitogen responsiveness of mononuclear cells from peripheral blood after epinephrine administration in humans. J. Immunol. 130: 694-697, 1983.
18. DEITCH, E. A. AND MCINTYRE BRIDGES, R.: Stress hormones modulate neutrophil and lymphocyte activity in vitro. J. Trauma 27: 1146-1153, 1987.
19. DONAHOE, R. M.: Neuroimmunomodulation by opiates: Relationship to HIV-1 infection and AIDS. Adv. Neuroimmunol. 3: 31-46, 1993.
20. EDWARDS, A. V.: Autonomic control of endocrine pancreatic and adrenal function. In Central Regulation of Autonomic Functions, ed. by A. D. Loewy and K. M. Spyer, pp. 286-309, Oxford University Press, Inc., New York, NY, 1990.
21. FECHO, K., DYKSTRA, L. A. AND LYSLE, D. T.: Evidence for beta adrenergic receptor involvement in the immunomodulatory effects of morphine. J. Pharmacol. Exp. Ther. 265: 1079-1087, 1993a.
22. FECHO, K., MASLONEK, K. A., DYKSTRA, L. A. AND LYSLE, D. T.: Alterations of immune status induced by the sympathetic nervous system: Immunomodulatory effects of DMPP alone and in combination with morphine. Brain Behav. Immun. 7: 253-270, 1993b.
23. FECHO, K., MASLONEK, K. A., DYKSTRA, L. A. AND LYSLE, D. T.: Assessment of the involvement of central nervous system and peripheral opioid receptors in the immunomodulatory effects of acute morphine treatment in rats. J. Pharmacol. Exp. Ther. 276: 626-636, 1996.
24. FELDMAN, R. D., HUNNINGHAKE, G. W. AND MCARDLE, W. L.: β-adrenergic receptor-mediated suppression of interleukin 2 receptors in human lymphocytes. J. Immunol. 139: 3355-3359, 1987.
25. FELTEN, D. L., FELTEN, S. Y., CARLSON, S. L., OLSCHOWKA, J. A. AND LIVNAT, S.: Noradrenergic and peptidergic innervation of lymphoid tissue. J. Immunol. 135: 755s-765s, 1985.
26. FLORES, L. R., HERNANDEZ, M. C. AND BAYER, B. M.: Acute immunosuppressive effects of morphine: Lack of involvement of pituitary and adrenal factors. J. Pharmacol. Exp. Ther. 268: 1129-1134, 1994.
27. FLORES, C. M., HERNANDEZ, M. C , HARGREAVES, K. M. AND BAYER, B. M.: Restraint stress-induced elevations in plasma coricosterone and β-endorphin are not accompanied by alterations in immune function. J. Neuroimmunol. 28: 219-225, 1990.
28. FREIER, D. O. AND FUCHS, B. A.: A mechanism of action for morphine-induced immunosuppression: Corticosterone mediates morphine-induced suppression of natural killer cell activity. J. Pharmacol. Exp. Ther 270: 1127-1133, 1994.
29. FRESA, K., HAMEED, M. AND COHEN, S.: Intracellular mechanisms of lymphoid cell activation. Clin. Immunol. Immunopathol 50: 8-19, 1989.
30. FUCHS, B. A. AND PRUETT, S. B.: Morphine induces apoptosis in murine thymocytes in vivo but not in vitro: Involvement of both opiate and glucocorticoid receptors. J. Pharmacol. Exp. Ther. 266: 417-123, 1993.
31. GEORGE, R. AND WAY, E. L.: The role of the hypothalamus in pituitary-adrenal activation and antidiuresis by morphine. J. Pharmacol. Exp. Ther. 125: 111-115, 1959.
32. GROSS, F. (ED.): International experience with nadolol, a long-acting β-blocking agent. In Royal Society of Medicine International Congress and Symposium Series, No. 37, pp. 9-38, Royal Society of Medicine and Academic Press Inc. Ltd., London, England, 1981.
33. HADDEN, J. W.: Transmembrane signals in the activation of T-lymphocytes by lectin mitogens. Mol. Immunol. 25: 1105-1112, 1988.
34. HADDEN, J. W. AND COFFEY, E. G.: Cyclic nucleotides in mitogen-induced lymphocyte proliferation. Immunol. Today 3: 299-304, 1982.
35. HADDEN, J. W., HADDEN, E. M. AND MIDDLETON, E., JR.: Lymphocyte blast transformation. I. Demonstration of adrenergic receptors in human peripheral lymphocytes. Cell. Immunol. 1: 583-595, 1970.
36. HALLAHAN, C., YOUNG, D. A. AND MUNCK, A.: Time course of early events in the action of glucocorticoids on rat thymus cells in vitro. J. Biol. Chem. 248: 2922-2927, 1973.
37. HENKART, P. A. AND FISHER, R. I.: Characterization of the lymphocyte surface receptors for Con A and PHA. J. Immunol. 114: 710-714, 1975.
38. HERNANDEZ, M. C., FLORES, L. R. AND BAYER, B. M.: Immunosuppression by morphine is mediated by central pathways. J. Pharmacol. Exp. Ther. 267: 1336-1341, 1993.
39. HOFFMAN, K. E., MASLONEK, K. A., DYKSTRA, L. A. AND LYSLE, D. T.: Effects of central administration of morphine on immune status in lewis and wistar rats. In The Brain Immune Axis and Substance Abuse, ed. by B. Sharp, T. Eisenstein, J. Madden and H. Friedman, pp. 155-159, Plenum Press, New York, NY, 1995.
40. JEFFERIES, W. MCK.: Cortisol and immunity. Med. Hypotheses 34: 198-208, 1991.
41. KANELLOPOULOS, J. M., DE PETRIS, S., LECA, G. AND CRUMPTON, M. J.: The mitogenic lectin from Phaseolus vulgaris does not recognize the T3 antigen of human T lymphocytes Eur. J. Immunol. 15: 479-486, 1985.
42. KURT-JONES, E. A., HAMBERG, S., OHARA, J., PAUL, W. E. AND ABBAS, A. K.: Heterogeneity of helper/induce T. lymphocytes. I. Lymphokine production and lymphokine responsiveness. J. Exp. Med. 166: 1774-1787, 1987.
43. LOTTI, V., KOKKA, N. AND GEORGE, R.: Pituitary-adrenal activation following intrahypothalamic microinjection of morphine. Neuroendocrinology 4: 326-332, 1969.
44. LOVELAND, B. E., JARROTT, B. AND MCKENZIE, I. F. C.: The detection of β-adrenoceptors on murine lymphocytes. Int. J. Immunopharmacol. 3: 45-55, 1981.
45. LYSLE, D. T., COUSSONS, M. E., WATTS, V. J., BENNETT, E. H. AND DYKSTRA, L. A.: Morphine-induced alterations of immune status: Dose-dependency, compartment specificity, and antagonism by naltrexone. J. Pharmacol. Exp. Ther. 265: 1071-1078, 1993.
46. 3H-clonidine binding in membranes prepared from guinea-pig spleen. Clin. Exp. Pharmacol. Physiol. 9: 77-87, 1982.
47. MILLER, A. H., SPENCER, R. L., STEIN, M. AND MCEWEN, B. S.: Adrenal steroid receptor bindingin spleen and thymus after stress or dexamethasone. Am J. Physiol. 259: E405-E412, 1990.
48. MINNEMAN, K. P., PITTMAN, R. N. AND MOLINOFF, P. B.: β-Adrenergic receptor subtypes:Properties, distribution and regulation. Annu. Rev. Neurosci. 4: 419-461, 1981.
49. MOSMANN, T. R., CHERWINSKI, H., BOND, M. W., GIEDLIN, M. A. AND COFFMAN, R. L : Two types of murine helper T. cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136: 2348-2357, 1986.
50. MUNCK, A. AND BRINCK-JOHNSEN, T.: Specific and nonspecific physiochemical interactions of glucocorticoids and related steroids with rat thymus cells in vitro. J. Biol. Chem. 243: 5556-5565, 1968.
51. NOWELL, P. C.: Inhibition of human leukocyte mitosis by prednisolone in vitro. Cancer Res. 21: 1518-1521, 1961.
52. PARKINSON, D.: Adrenergic receptors in the autonomic nervous system. In Central Regulation of Autonomic Functions, ed. by A. D. Loewy and K. M. Spyer, pp. 17-27, Oxford University Press, Inc., New York, NY, 1990.
53. PETERSON, P. K., MOLITOR, T. W. AND CHAO, C. C.: Mechanisms of morphine-induced immunomodulation. Biochem. Pharmacol. 46: 343-348, 1993.
54. PLUMMER, A. J., TRAPOLD, J. H., SCHNEIDER, J. A., MAXWELL, R. A. AND EARL, A. E.: Ganglionic blockade by a new bisquaternary series, including chlorisondamine dimethochloride. J. Pharmacol. Exp. Ther. 115: 172-184, 1955.
55. PROSS, H. F. AND MAROUN, J. A.: The standardization of NK cell assays for use in studies of biological response modifiers. J. Immunol. Methods 68: 235-249, 1984.
56. PRUETT, S. B., HAN, Y.-C. AND FUCHS, B. A.: Morphine suppresses primary humoral immune responses by a predominantly indirect mechanism. J. Pharmacol. Exp. Ther. 262: 923-928, 1992.
57. RADOJCIC, T., BAIRD, S., DARKO, D., SMITH, D. AND BULLOCH, K.: Changes in β-adrenergic receptor distribution on immunocytes during differentiation: An analysis of T cell and macrophages. J. Neurosci. Res. 30: 328-335, 1991.
58. RED, J. L. AND KOPIN, I. J.: The effects of ganglionic blockade, reserpine and vinblastine on plasma catecholamines and dopamine β-hydroxylase in the rat. J. Pharmacol. Exp. Ther. 193: 748-756, 1975.
59. SEI, Y., MCINTYRE, T., FRIDE, E., YOSHIMOTO, K., SKOLNICK, P. AND ARORA, P. K.: Inhibition of calcium mobilization is an early event in opiate-induced immunosuppression. FASEB J. 5: 2194-2199, 1991a.
60. SEI, Y., YOSHIMOTO, K., MCINTYRE, T., SKOLNICK, P. AND ARORA, P. K.: Morphine-induced thymic hypoplasia is glucocorticoid-dependent. J. Immunol. 146: 194-198, 1991b.
61. SHAVIT, Y., DEPAULIS, A., MARTIN, F. C., TERMAN, G. W., PECHNICK, R. N., ZANE, C. J., GALE, R. P. AMD LIEBESKIND, J. C.: Involvement of brain opiate receptors in the immune-suppressive effect of morphine. Proc. Natl. Acad. Sci. U.S.A. 83: 7114-7117, 1986.
62. STITES, D. P.: Clinical laboratory methods for detection of cellular immune function. In Basic and Clinical Immunology, 8th ed., ed. by D. P. Stites, A. I. Terr and T. G. Parslow, pp. 195-215, Appleton and Lange, East Norwalk, CT, 1994.
63. SUEMARU, S., HASHIMOTO, K. AND OTA, Z.: Effect of morphine on hypothalamic corticotropin-releasing factor (CRF) and pituitary-adrenocortical activity. Endocrinol. Jpn. 33: 441-448, 1986.
64. TRUNCH, A., ALBERT, F., GOLDSTEIN, P. AND SCHMITT-VERHULST, A.: Early stages of lymphocyte activation bypassed by eynergy between calcium ionophores and phorbol ester. Nature 313: 318-320, 1985.
65. VAN VOORHIS, B. J., ANDERSON, D. J. AND HILL, J. A.: The effects of RU 486 on immune function and steroid-induced immunosuppression in vitro. J. Clin. Endocrinol. Metab. 69: 1195-1199, 1989.
66. WEBEL, M. L. AND RITTS, R. E., JR.: The effects of corticosteroid concentrations on lymphocyte blastogenesis. Cell. Immunol. 32: 287-292, 1977.
67. WEBER, R. J. AND PERT, A.: The periaqueductal gray matter mediates opiate-induced immunosuppression. Science 245: 188-190, 1989.
68. WERB, Z., FOLEY, R. AND MUNCK, A.: Interaction of glucocorticoids with macrophages: Identification of glucocorticoid receptors in monocytes and macrophages. J. Exp. Med. 147: 1684-1694, 1978.
69. WIEGERS, G. J., CROISET, G., REUL, J. M. H. M., HOLSBOER, F. AND DEKLOET, E. R.: Differential effects of corticosteroids on rat peripheral blood T-lymphocyte mitogenesis in vivo and in vitro. Am J. Physiol. 265: E825-E830, 1993.
70. 3H]alprenolol binding. J. Clin. Invest. 57: 149-155, 1976.
71. WOODS, P. B. AND ROBINSON, M. L.: An investigation of the comparative liposolubilities of β-adrenoceptor blocking agents. J. Pharm. Pharmacol. 33: 172-173, 1981.